Results of surgery for malignant bowel obstruction in advanced, unresectable, recurrent colorectal cancer

Published on Jan 1, 1993in Diseases of The Colon & Rectum4.785
路 DOI :10.1007/BF02050303
Peter W. K. Lau8
Estimated H-index: 8
(HKU: University of Hong Kong),
Theo G. Lorentz6
Estimated H-index: 6
(HKU: University of Hong Kong)
When conservative treatment fails in the management of patients with malignant bowel obstruction secondary to advanced, recurrent colorectal cancer, the attitude toward surgery is often less than enthusiastic because of the limited life expectancy. We report a retrospective review of 30 patients with unresectable intra-abdominal disease who underwent laparotomy for the relief of bowel obstruction. Normal bowel function was restored in 19 patients (63 percent). The failures included five patients (17 percent) who died as a result of surgical complications and six patients (20 percent) who despite the surgery had continuing obstruction. Postoperative complications occurred in eight patients (27 percent). The median survival was significantly improved in those who benefited from the operation (192 daysvs.26 days;P= 0.0001). Whether the obstruction occurred at one site or more than one site appeared not to influence the outcome of surgery. Obstruction recurred after a mean symptomfree interval of 120 days in eight of those relieved by the initial operation. Half of these patients responded to conservative treatment, and surgery was again beneficial in three of the remaining four. Our results justify a more positive approach toward this problem, and, when conservatism fails, laparotomy should be undertaken in those who are not terminally ill.
馃摉 Papers frequently viewed together
198579.32The Lancet
3 Authors (Mary Baines, ..., R.L. Carter)
#1Alan D. Turnbull (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 30
#2J GuerraH-Index: 1
Last. H F StarnesH-Index: 1
view all 3 authors...
Results of operation for obstructing carcinomatosis of gastrointestinal (GI), pancreatic, or biliary origin were reviewed to assess relief of symptoms, management of re-obstruction, and duration of hospitalization. A retrospective review (1977 to 1986) identified 89 patients, 59 (66%) of whom had tumors originating in the colon, and 19 (21%) in the stomach. Normal bowel function was restored for a median of 102 days in 66 patients (74%) and all but four (94%) were discharged. Forty-one (46%) pat...
#1Hubert SpearsH-Index: 1
Last. Amold MittelmanH-Index: 1
view all 4 authors...
Summary Operative therapy is beneficial in patients with bowel obstruction after operation for colorectal carcinoma. The cause of the bowel obstruction is more likely to be benign following colorectal carcinoma than following other malignancies. Also, the period of preoperative nasogastric suction can safely be extended to 3 to 4 days in these patients, since a resolution rate of 28 percent can be achieved with minimal risk of strangulation.
#1Mary BainesH-Index: 2
#2D.J. OliverH-Index: 1
Last. R.L. CarterH-Index: 23
view all 3 authors...
Abstract A clinical and pathological study was made of 40 patients with intestinal obstruction due to far-advanced abdominal and/or pelvic malignant disease. Surgical intervention was feasible in only 2 cases. The remaining 38 patients were managed medically without intravenous fluids and nasogastric suction. Obstructive symptoms such as intestinal colic, vomiting, and diarrhoea were effectively controlled by drugs.
: The records of 66 consecutive patients who developed intestinal obstructions after treatment for cancer were reviewed. Approximately one third of the patients were found to have a benign cause of obstruction. The chances that an obstruction was due to cancer were increased if the patient had known metastatic cancer, previous colorectal cancer, if the primary was an advanced stage, and if the interval since treatment of the primary was short. Incomplete obstructions were treated with nasogastri...
#1Levine DfH-Index: 1
#2Marshall AjH-Index: 1
Last. T. EhrenspergerH-Index: 3
view all 2 authors...
#1Alfred S. Ketcham (NIH: National Institutes of Health)H-Index: 53
#2Robert C. Hoye (NIH: National Institutes of Health)H-Index: 23
Last. Donald L. Morton (NIH: National Institutes of Health)H-Index: 21
view all 4 authors...
A review of 117 patients who have been treated for cancer and subsequently developed 173 episodes of intestinal obstruction has established guidelines for the management of the cancer patient with abdominal distress. Operative intervention is the treatment of choice for intestinal obstruction occurring in a patient previously treated for a malignant neoplasm. Approximately one fourth of such patients will have intestinal obstructions which are not caused by recurrence of, or metastases from, the...
Cited By50
#1Samuel P. Banting (Peter MacCallum Cancer Centre)
#2Peadar S Waters (Peter MacCallum Cancer Centre)H-Index: 6
Last. Alexander G. Heriot (Peter MacCallum Cancer Centre)H-Index: 57
view all 8 authors...
BACKGROUND: The management of patients presenting with malignant small bowel obstruction is a challenging paradigm. The aim of this systematic review was to examine different management strategies in these complex patients. The primary outcomes evaluated were the type of intervention, 30-day morbidity and mortality and overall survival rates. METHODS: A systematic literature review of EMBase, Medline, PubMed and the Cochrane Library was performed using Preferred Reporting Items for Systematic re...
#1Robert J. Litwin (BCM: Baylor College of Medicine)H-Index: 1
#2Johanna L. Chan (BCM: Baylor College of Medicine)H-Index: 1
Last. Steven Y. Huang (University of Texas MD Anderson Cancer Center)H-Index: 17
view all 3 authors...
Malignant bowel obstruction (MBO) is a relatively common condition affecting patients with advanced malignancy. Therapeutic interventions should be aimed at maintaining quality of life. Given the lack of prospective controlled studies in this patient population, patient management is often based on local practice patterns and anecdotal experience. To foster a collaborative approach among the members of the patient care team involving internal medicine, oncology, palliative care, clinical nutriti...
#2David Santos (University of Texas Health Science Center at Houston)H-Index: 1
: Background: Malignant intestinal obstruction is a frequent complication in advanced stages cancer patients. The prognosis is poor, with mean survival rate beneath 3 months. Clinical treatment, endoscopic or surgical procedures are options for malignant intestinal obstruction management. There is no generally accepted management strategy. Objectives: To evaluate prognostic factors of patients with malignant intestinal obstruction who underwent surgical treatment. Methods: A retrospective analys...
#1Nadine L. de Boer (EUR: Erasmus University Rotterdam)H-Index: 5
#2J.A.W. Hagemans (EUR: Erasmus University Rotterdam)H-Index: 9
Last. Jacobus W. A. Burger (EUR: Erasmus University Rotterdam)H-Index: 23
view all 7 authors...
Abstract Introduction Patients with peritoneal carcinomatosis who do not have curative treatment options often develop acute obstructive symptoms and when conservative management fails, surgical treatment is the remaining option. However, palliative surgery is associated with high morbidity and mortality and the chance of success is unclear. The aim of this study was to evaluate outcomes of palliative surgery and to provide guidance for surgeons, medical oncologists and patients in their decisio...
Abstract Background Several authors have reported on the utility of a laparoscopic approach for the palliation of malignant bowel obstruction (MBO); however, the advantages of laparoscopic surgery for MBO have not yet been confirmed. Methods We retrospectively reviewed the medical records of patients who underwent palliative surgery for MBO between 2007 and 2015. Laparoscopic procedures have been performed when technically possible since 2014. Successful palliation was defined as the ability to ...
#1Douglas J. Koo (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 5
#2Tabitha N. Goring (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 4
Last. Barbara Egan (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 5
view all 4 authors...
#1Sarah E Cousins (Barts Health NHS Trust)H-Index: 1
#2Emma TempestH-Index: 1
Last. David J Feuer (Barts Health NHS Trust)H-Index: 2
view all 3 authors...
Background This is an update of the original Cochrane review published in Issue 4, 2000. Intestinal obstruction commonly occurs in progressive advanced gynaecological and gastrointestinal cancers. Management of these patients is difficult due to the patients' deteriorating mobility and function (performance status), the lack of further chemotherapeutic options, and the high mortality and morbidity associated with palliative surgery. There are marked variations in clinical practice concerning sur...
#1Terrah J. Paul Olson (UW: University of Wisconsin-Madison)H-Index: 6
#2Carolyn Pinkerton (MCW: Medical College of Wisconsin)H-Index: 1
Last. Margaret L. Schwarze (UW: University of Wisconsin-Madison)H-Index: 20
view all 4 authors...
Importance Care of patients with malignant bowel obstruction caused by peritoneal metastases may present an ethical dilemma for surgeons when nonoperative management fails. Objective To characterize outcomes of palliative surgery for malignant bowel obstruction from peritoneal carcinomatosis to guide decision making about surgery and postoperative interventions for patients with terminal illness. Evidence Review We searched PubMed, EMBASE, Cochrane Library, Web of Knowledge, Cumulative Index to ...
#1Brian D. BadgwellH-Index: 24
#2Robert S. Krouse (UA: University of Arizona)H-Index: 35
Last. Eduardo Bruera (University of Texas MD Anderson Cancer Center)H-Index: 128
view all 4 authors...
Abstract Objective: To prospectively evaluate outcome measures of patients undergoing palliative surgical evaluation for gastrointestinal obstruction. Methods: Patients with an incurable malignancy undergoing consultation for gastrointestinal obstruction were prospectively enrolled from November 2009 to July 2012. We evaluated two patient-reported outcome measures of quality of life (Functional Assessment of Cancer Therapy-General [FACT-G]) and treatment satisfaction (Functional Assessment of Ch...
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.